Kinaset Therapeutics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Kinaset Therapeutics

Access the complete profile.

Kinaset Therapeutics Fast Facts

Revenue	Less than $1 million    See Exact Annual Revenue
Employees	1 - 10Exact Company Size
Primary Industry	325412 Pharmaceutical Preparation Manufacturing
Additional NAICS Codes	62133 Offices of Mental Health Practitioners
Address	10 Knollwood Road Medfield, MA 02052

Note: Revenues for privately held companies are statistical evaluations.


Kinaset Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Kinaset Therapeutics's annual revenues are Less than $1 million (see exact revenue data)
• What industry is the company in?
  • Kinaset Therapeutics is classified as operating in the Pharmaceutical Preparation Manufacturing industry, NAICS Code 325412.

Kinaset Therapeutics Annual Revenue and Growth Rate

Kinaset Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	Less than $1 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Kinaset Therapeutics's revenues are gauged from an analysis of company filings.

Kinaset Therapeutics's Income Statement (based on Industry Averages)

Kinaset Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Kinaset Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
July 17, 2023	3	70%	$41 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Kinaset Therapeutics is developing and marketing. Kinaset Therapeutics doesn't have any recent trademark applications, indicating Kinaset Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
KINASET THERAPEUTICS Development of pharmaceuticals and therapeutics	12/14/2020

See all trademarks and details in the Full Report.

Market Share of Kinaset Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Kinaset Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
MERIDIAN MEDICAL TECHNOLOGIES	Columbia, MD	100
SYNTRON BIORESEARCH	Carlsbad, CA	55
RLS USA	Lake Zurich, IL	49
ALORA PHARMACEUTICALS	Alpharetta, GA	42
LANTHEUS HOLDINGS	North Billerica, MA	33
BROADVIEW INVESTMENTS	Royston, GA	32
RESULTS RNA	Orem, UT	29
CIVICA	Lehi, UT	28
HARMONY BIOSCIENCES	Plymouth Meeting, PA	24

Nearby Competitors

These companies are similar in business line and location to Kinaset Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
RUBIUS THERAPEUTICS	Foxborough, MA	100
KALEIDO BIOSCIENCES	Foxborough, MA	21
APTINYX	Foxborough, MA	8
1GLOBE HEALTH INSTITUTE	Norwood, MA	8
CORBUS PHARMACEUTICALS	Norwood, MA	7
RARE BEAUTY BRANDS	Norwood, MA	6

Future Competition: Kinaset Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Kinaset Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)